NCT04672018View on ClinicalTrials.gov

Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis

PHASE2CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

November 8, 2022

Primary Completion Date

February 2, 2023

Study Completion Date

February 2, 2023

Conditions
Gastritis
Interventions
OTHER

Houtou Jianweiling tablet

Houtou Jianweiling tablet (0.38 g), 4 tablets taken orally at a time, 3 times a day and Omeprazole Enteric-coated placebo tablet, taken 1 tablet orally once a day before breakfast.

DRUG

Omeprazole Tablet

Omeprazole Enteric-coated tablet (20 mg), 1 tablet taken orally once a day before breakfast and Houtou Jianweiling placebo tablets, taken orally, 4 tablets at a time, 3 times a day.

Trial Locations (1)

75270

Center for Bioequivalence Studies and Clinical Research (CBSCR), ICCBS, university of Karachi, Karachi

All Listed Sponsors
collaborator

Hunan Xinhui Pharmacy Limited Company

UNKNOWN

lead

University of Karachi

OTHER